BamSEC and AlphaSense Join Forces
Learn More

Theriva Biologics, Inc.

NYSE American: TOVX    
Share price (12/20/24): $1.14    
Market cap (12/20/24): $3.172 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.4
from S-1 8 pages Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 8 pages Placement Agency Agreement
12/34/56
EX-1.4
from S-1 8 pages Placement Agency Agreement
12/34/56
EX-1.2
from 8-K 3 pages Amendment No. 1 to Amended and Restated at Market Issuance Sales Agreement
12/34/56
EX-1.1
from 8-K 43 pages Synthetic Biologics, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Amended and Restated at Market Issuance Sales Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 45 pages Underwriting Agreement Between Synthetic Biologics, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Synthetic Biologics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Underwriting Agreement Between Synthetic Biologics, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Synthetic Biologics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Underwriting Agreement Between Synthetic Biologics, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Synthetic Biologics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Underwriting Agreement Between Synthetic Biologics, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Synthetic Biologics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 5 pages Amendment No. 1 to At-The-Market Issuance Sales Agreement
12/34/56
EX-1.1
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-1.1
from 8-K 36 pages Synthetic Biologics, Inc. 25,000,000 Shares of Common Stock Series a Warrants to Purchase 25,000,000 Shares of Common Stock Series B Warrants to Purchase 25,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Synthetic Biologics, Inc. Shares of Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-1.1
from 8-K 35 pages Synthetic Biologics, Inc. 13,333,333 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13D/A 1 page Joint Filing Agreement
12/34/56
EX-1.2
from 8-K 3 pages Synthetic Biologics, Inc. Controlled Equity Offeringsm Amendment No. 1 to Sales Agreement
12/34/56
EX-1.1
from 8-K 41 pages Underwriting Agreement Between Synthetic Biologics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters 11,500,000 Shares of Common Stock Synthetic Biologics, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3 45 pages Synthetic Biologics, Inc. Up to $ 15,000,000 of Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 8 pages Confidential July 2, 2010 Adeona Pharmaceuticals, Inc. 3985 Research Park Drive Ann Arbor, MI 48108 Attn: James S. Kuo M.D. Re: Financing Placement Dear Jim
12/34/56